Live
One Link Live rooms, co-hosting, captions, gifts and community tools.

OneLinkUS
GHOST OMNI DIVINE IS GOD LLC
OneLinkUS.com
Sign in with an existing subscription to unlock visual layouts.
Browse worldwide headlines, search any country or region, and choose a topic. Publisher photographs and video appear when available from the news source.
Explore news by country, topic and format →Headlines from publishers around the world. Search any country, region or topic.
No headlines found. Try a broader topic.
More world news →9 results for “United States WHO approves trials for two new Ebola vaccines - Yahoo live news”
Showing OneLink and reference results. Broader web, photo and video coverage is awaiting the search provider connection.
One Link Live rooms, co-hosting, captions, gifts and community tools.
Worldwide problem-solving, official services, emergency guidance and reliable next steps.
Advanced platform connections, AI, backend and service status.
The 2013–2016 epidemic of Ebola virus disease, centered in West Africa, was the most widespread outbreak of the disease in history. It caused major loss of life and socioeconomic disruption in the region, mainly in Guinea, Liberia and Sierra Leone.
Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company developed the Novavax COVID-19 vaccine, now commercialized by Sanofi.
Four laboratory-confirmed cases of Ebola virus disease (commonly known as "Ebola") occurred in the United States in 2014. Eleven cases were reported, including these four cases and seven cases medically evacuated from other countries.
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax among others, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA). Depending on the jurisdiction, it is authorized for use in humans aged six months, twelve years, or eighteen years and older.
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing.
In 2025, at least 50 COVID-19 vaccines have received authorization in one or more countries — meaning they have been approved, licensed, or granted emergency use authorization by national regulatory authorities around the world in 201 country. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIB